Inhibition of histone deacetylase suppresses osteoclastogenesis and bone destruction by inducing IFN-beta production. - Wikidata - wikimedia - TriplyDB

Inhibition of histone deacetylase suppresses osteoclastogenesis and bone destruction by inducing IFN-beta production.

Inhibition of histone deacetylase suppresses osteoclastogenesis and bone destruction by inducing IFN-beta production.

http://www.wikidata.org/entity/Q46763990

about

The Modulatory Effects of Mesenchymal Stem Cells on Osteoclastogenesis Histone deacetylase inhibitor MS-275 stimulates bone formation in part by enhancing Dhx36-mediated TNAP transcription Histone deacetylase 3 supports endochondral bone formation by controlling cytokine signaling and matrix remodeling.Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma.Histone deacetylases in skeletal development and bone mass maintenance.(+)-Vitisin A inhibits osteoclast differentiation by preventing TRAF6 ubiquitination and TRAF6-TAK1 formation to suppress NFATc1 activation Hdac-mediated control of endochondral and intramembranous ossification Histone Deacetylases in Bone Development and Skeletal Disorders.The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma.Histone deacetylases in control of skeletogenesis.HDAC7 inhibits osteoclastogenesis by reversing RANKL-triggered β-catenin switch.Materials in particulate form for tissue engineering. 2. Applications in bone.Targeting histone deacetylase activity in rheumatoid arthritis and asthma as prototypes of inflammatory disease: should we keep our HATs on?Epigenetics in rheumatoid arthritis.HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis.HDAC inhibitors: modulating leukocyte differentiation, survival, proliferation and inflammation.Epigenomic deregulation in the immune system.Panobinostat for the treatment of multiple myeloma.Histone deacetylase inhibitors as suppressors of bone destruction in inflammatory diseases.Epigenetics and Bone Remodeling.Class I and IIa histone deacetylases have opposite effects on sclerostin gene regulation.Epigenetic drug discovery: breaking through the immune barrier.BIX01294 suppresses osteoclast differentiation on mouse macrophage-like Raw264.7 cells.Nordihydroguaiaretic acid inhibition of NFATc1 suppresses osteoclastogenesis and arthritis bone destruction in rats.A possible suppressive role of galectin-3 in upregulated osteoclastogenesis accompanying adjuvant-induced arthritis in rats.The histone deacetylase inhibitor, PXD101, potentiates bortezomib-induced anti-multiple myeloma effect by induction of oxidative stress and DNA damage.Antitumor activity of the histone deacetylase inhibitor MS-275 in prostate cancer models.Epigenetic regulation in bacterial infections: targeting histone deacetylases.Histone deacetylase inhibitors: a new and promising drug class for the treatment of arthritis?Class II and IV HDACs function as inhibitors of osteoclast differentiation.Histone deacetylase inhibitors and periodontal bone loss.Inhibition of HDAC activity by ITF2357 ameliorates joint inflammation and prevents cartilage and bone destruction in experimental arthritis.Histone deacetylase inhibitors MS-275 and SAHA induced growth arrest and suppressed lipopolysaccharide-stimulated NF-kappaB p65 nuclear accumulation in human rheumatoid arthritis synovial fibroblastic E11 cells.Valproic acid exerts anti-tumor as well as anti-angiogenic effects on myeloma.Osteoimmunology: The Conceptual Framework Unifying the Immune and Skeletal Systems.Adenosine abolishes MTX-induced suppression of osteoclastogenesis and inflammatory bone destruction in adjuvant-induced arthritis.The effects of JNJ-26481585, a novel hydroxamate-based histone deacetylase inhibitor, on the development of multiple myeloma in the 5T2MM and 5T33MM murine models.Class I and II histone deacetylase expression in human chronic periodontitis gingival tissue.Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis

P2860

Q26773017-1DCAE7D6-BE54-4AD4-B9F4-5802A2D27FF3 Q28505369-2877BED1-3439-4941-A95A-8D63BB2A1199 Q33614697-77E95651-3829-4F7F-9165-263415A6BFFE Q34441748-89C576EB-CBDB-4878-AC3D-5D421774752B Q34612849-A0D4FFA1-6FD2-4E79-9E92-C0416D57D3AB Q35099825-F65BB5B6-DA16-41CE-B04C-6147E1FDAB4E Q35556841-1E22F6B5-00B9-47D7-B608-EF76B1986CA0 Q36146330-DBB0AFB4-CAA8-42DF-A45A-E1316F9B3CA1 Q36870585-29E8AE0E-54C2-4941-8D9E-2E3FC64771C0 Q36895484-BB29C85B-21D2-4E4E-B8D3-F6FB9D783543 Q36932525-A171C137-1F40-4E64-B929-D85BA400CB27 Q37014341-AAE9307A-1129-4B90-8252-343DE7AF7D59 Q37317209-0F5F8B7F-97AB-45EF-ABC8-63F50E647BD4 Q37587047-50184D1E-C435-4D4B-A776-45097D38FE29 Q37838731-071C372D-80A6-4871-A017-41DCEEF94DED Q37949185-E1D4B1F5-58EA-4A4D-939D-9C6BB239C90C Q37962605-B0DDE14F-9EBE-4996-B5FB-46A0371A586E Q37992104-5F117B10-B14A-4340-B502-D8A41B21D398 Q38008692-39341912-FEE0-421D-AEF5-3549E94CDBBB Q38624611-412B3F64-FF45-49F6-A68B-B0E269E596E2 Q38976490-E1B5DFF3-4C6D-4ABF-9139-72D735997CF6 Q38986705-1418B837-1465-4FA6-8B60-3573E3EAE237 Q39052002-82625A17-5022-4824-AF01-3116C1520FE7 Q39264023-4F6E2A35-0EF4-4898-B78B-E08B4D7A42B0 Q39915429-DE1D53ED-B291-4D3D-B9EA-ABD4E559C2A3 Q40073382-3A67A79B-37E9-4C1F-9839-D065B0D775A9 Q40129051-588CF545-BA76-4C7A-AA6B-176982062504 Q41991798-06E2DC22-DB3A-489C-807D-841AE826EB1B Q42182612-B43CF223-83E9-4E39-A1E2-AD5CF5E11627 Q42220685-FD58CE02-C3BC-4B5E-B83E-AC5B903C84EE Q42730771-AB0C79EE-9986-4AD4-AAE2-E43784F13AAB Q42742359-B085E7E1-34E0-45AB-8499-A915E94E2985 Q43084969-D3E6411F-4343-4DEF-B617-F0DC7707B01C Q46192240-63D6B89A-2A29-4D02-A948-AD69DBC9268A Q47944184-ADABDAF7-3408-487D-B8F3-7E081F642C72 Q50115228-0783375C-0316-4674-B95A-AD9694694C90 Q53391458-5E983DDD-1CD9-4F5B-8DD7-98DDF02D5704 Q54161049-D283E3EF-D9AE-48BE-9819-60931EE9FC5E Q57080806-9AC95CA0-DDBB-4B3F-BFD4-6E4634EBEB91

P2860

Inhibition of histone deacetylase suppresses osteoclastogenesis and bone destruction by inducing IFN-beta production.

http://www.wikidata.org/entity/Q46763990

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Inhibition of histone deacetyl ...... inducing IFN-beta production.

@en

Inhibition of histone deacetyl ...... inducing IFN-beta production.

@nl

type

label

Inhibition of histone deacetyl ...... inducing IFN-beta production.

@en

Inhibition of histone deacetyl ...... inducing IFN-beta production.

@nl

prefLabel

Inhibition of histone deacetyl ...... inducing IFN-beta production.

@en

Inhibition of histone deacetyl ...... inducing IFN-beta production.

@nl

P1433

Q46763990-E68CD229-E480-4764-9153-171061386C8A

P1476

Q46763990-1FAE634E-61BD-48BB-9179-7BAD8A58D13E

P2093

Q46763990-0320B088-106B-4E75-BD76-17CC6F211D5E

Q46763990-16E8F77F-48ED-405C-B847-F9436C07A4FF

Q46763990-20CDF0F8-A17E-43D4-9B37-DE92F58DDE8B

Q46763990-31EB82FC-6A1F-4224-9D10-B0673BC57E6D

Q46763990-688C441F-28A5-4DD2-82F0-C1011D01A51B

Q46763990-75F96FF1-25CE-4AC3-9C48-CD13EF39C409

Q46763990-79041204-DA0E-48E6-8B3A-7214DE3FD06F

Q46763990-86D6C7A9-79A3-4F33-965D-E42C2A2FAA3A

Q46763990-AC0121E2-63FE-48B8-A4BD-0D5936698382

P304

Q46763990-08FBD684-FDE1-4F9C-80AD-07DEF5228118

P31

Q46763990-E71F4248-19CB-4310-988F-B081B4DD8979

P356

Q46763990-47EDF2C8-4D15-4709-BDFF-78D216ABE929

P407

Q46763990-F975363B-31A9-4937-A42F-950CEFBFBD2B

P433

Q46763990-09424F4E-061D-47DF-A80B-B134E37BA4D8

P478

Q46763990-0EE456DE-B04E-4643-9590-FF9D55B85BFD

P577

Q46763990-1E2035D4-16E0-4B96-94B9-E77843E84D58

P5875

Q46763990-8D016D07-FB03-49B5-83D6-36ED635F6150

P698

Q46763990-B9832DB8-8CF6-4265-8B26-F8A7215C7B7A

P356

JIMMUNOL.175.9.5809

P1433

Journal of Immunology

P1476

Inhibition of histone deacetyl ...... inducing IFN-beta production.

@en

P2093

Akiko Kukita

http://www.w3.org/2001/XMLSchema#string

Kengo Nagata

http://www.w3.org/2001/XMLSchema#string

Kenji Ogawa

http://www.w3.org/2001/XMLSchema#string

Osamu Kohashi

http://www.w3.org/2001/XMLSchema#string

Takahiro Nakamura

http://www.w3.org/2001/XMLSchema#string

Takao Hotokebuchi

http://www.w3.org/2001/XMLSchema#string

Takeo Shobuike

http://www.w3.org/2001/XMLSchema#string

Toshio Kukita

http://www.w3.org/2001/XMLSchema#string

Zhou Wu

http://www.w3.org/2001/XMLSchema#string

P304

5809-5816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.175.9.5809

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

175

http://www.w3.org/2001/XMLSchema#string

P577

2005-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7529586

http://www.w3.org/2001/XMLSchema#string

P698

16237073

http://www.w3.org/2001/XMLSchema#string